Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.

Although our study is limited in the number of cases examined and did not have the necessary power to distinguish early and late stages of liver cancer, it is remarkable that even with a small sample size (cancer: n = 16, normal: n = 16) we were able to obtain highly significant results ( Figure 4D ).

also in 132,142 other papers